Intrexon | XON - Ebitda





Ebitda Veränderung Datum
Agenus USD -10.11M 19.02M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Amgen USD 3.86B 1.28B 2026-03
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD -147.68M 40.33M 2026-06
AstraZeneca USD 5.16B 510M 2026-06
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Gilead Sciences USD 3.51B 489M 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Heron Therapeutics USD -3.88M 5.63M 2024-09
Incyte USD 778.57M 410.6M 2026-06
Intrexon USD -24.7M 2.92M 2024-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD -14.3M 81.08M 2026-03
MacroGenics USD -30.2M 52.15M 2026-03
MannKind USD 2.93M 5.98M 2026-03
Merck USD -1.54B 7.84B 2026-03
Novartis USD 6.48B 1.19B 2026-06
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Roche Holding CHF 13.43B 744M 2026-06
Thermo Fisher Scientific USD 3.55B 845M 2026-06
Veracyte USD 43.96M 1.16M 2026-06
Xencor USD -34.63M 86.74M 2026-06